Skip to content

MiNK Therapeutics, Inc.

INKT · XNAS

CIK 1840229fmd_1VT2THAT8KK19DAXKWVX3X928BManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading